Digital Autism Therapy System for Drug-Free Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for autism in children are ineffective and lack clear therapeutic methods, with no established cause identified, leading to increased prevalence and regression of symptoms, particularly in mild cases, and existing methods do not provide comprehensive recovery without drug use.
Innovation Solution
A therapeutic system comprising a management server, network, and client terminal that determines the child's brain type and provides specific missions to guardians to address neural network damage, promote neurotransmitter production, and prevent symptom regression, allowing for drug-free treatment of autism in children under 12 years old.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (drugs or herbal medicine) are used for autism, then some symptomatic relief may be achieved, but complete recovery is not guaranteed and side effects or lack of efficacy persist
Solution Approach 1:
The patent replaces pharmacological treatments (chemical system) with a digital information-based system that provides structured missions and environmental modifications. The management server delivers customized intervention programs without using drugs, thereby eliminating medication side effects while aiming to achieve complete recovery through systematic environmental and behavioral modifications.
Solution Approach 2:
The system changes the approach from chemical intervention to modifying environmental parameters and behavioral conditions. By adjusting mission difficulty, treatment duration, and environmental factors through the digital platform, the system seeks to achieve therapeutic effects without pharmaceutical substances, thereby avoiding drug-related harm while improving reliability of complete recovery.
2Productivity
If no specific treatment method is applied, then the natural progression of autism occurs, but mild cases regress to more severe levels over time
Solution Approach 1:
The system implements preliminary diagnostic assessment to identify autism brain type and severity level before initiating treatment. This preliminary characterization allows the management server to prescribe appropriate mission groups in advance, preventing symptom regression by early intervention rather than waiting for deterioration to occur.
Solution Approach 2:
The system incorporates continuous feedback mechanisms where the management server monitors treatment progress through guardian input and adjusts mission prescriptions accordingly. This feedback loop ensures that treatment intensity and type are optimized to prevent regression while accelerating recovery, adapting to the child's improving condition in real-time.
3Measurement precision
If a comprehensive diagnostic and treatment system is implemented, then accurate brain type determination and customized treatment can be achieved, but system complexity increases
Solution Approach 1:
The management server performs multiple functions including diagnostic assessment, brain type determination, mission prescription, progress monitoring, and treatment adjustment within a single integrated digital platform. This multi-functionality achieves comprehensive diagnostic precision without proportionally increasing system complexity, as one system handles all treatment phases.
Solution Approach 2:
The system enables guardians to input treatment progress and observe improvements through the digital platform without requiring constant professional intervention. The management server automatically processes data, determines therapeutic effects, and adjusts missions, reducing the need for complex manual assessments while maintaining high measurement precision through standardized digital protocols.
Data Source
AI summary
A therapeutic system for children's autism including a management server, a network, a client terminal and a database, wherein the management server includes a subject determination unit that determines whether or not the subject corresponds to the brain type to be treated through the client terminal; a mission presentation unit that presents a mission to a guardian through the client terminal if the subject corresponds to the brain type to be treated; an effect determination unit that determines whether or not there is a therapeutic effect through the treatment progress input through the client terminal after the guardian's mission is progressed; and a result output unit that outputs the determination result of the effect determination unit to the client terminal.